Original Literature | Model OverView |
---|---|
Publication
Title
Genetic regulation of macrophage priming/activation: the Lsh gene story.
Affiliation
Department of Medical Parasitology, London School of Hygiene and TropicalMedicine, U.K.
Abstract
This paper describes functional and genetic studies on the macrophage resistancegene Lsh/Ity/Bcg first described almost two decades ago. Working in vitro withresident peritoneal, liver (Kupffer cells) and bone marrow derived macrophagesfrom congenic B10 (LshS) and B10.L-LshR mice it has been possible to demonstratethat the final effector mechanism for the gene in regulating antileishmanialactivity involves production of reactive nitrogen rather than reactive oxygenintermediates. This in turn is dependent upon priming/activation of macrophagesfor enhanced TNF-alpha release which acts back on the macrophage in an autocrinemanner to increase nitric oxide production. The precise point at which Lsh actsto control macrophage priming/activation has not been identified, but studies ofearly response gene expression show differences in KC mRNA levels at 2 h afterLPS stimulation, and in c-fos mRNA as early as 20 min after stimulation with PMAplus ionophore, in peritoneal macrophages from congenic LshS and LshR mice. Dataavailable suggest that both negative and positive signals may be involved inmacrophage priming/activation, with LshS macrophages down-regulating theircapacity for continued response to the autocrine loop. Work in progress willexamine the role of TPA and cAMP response element-binding proteins in regulatinggene expression in Lsh congenic mice. A major new initiative has also commencedto clone the Lsh gene by reverse genetics using yeast artificial chromosomes towalk towards Lsh from the closet proximal and distal markers on mouse chromosome1.(ABSTRACT TRUNCATED AT 250 WORDS)
PMID
1757110
|
Entity
c-fos
--
G010214
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m93203
10
infinite
0
TRANSFAC | G010214 |
--
TNF-alpha
--
G010329
cso30:c:mRNA
cso30:i:CC_CellComponent
--
csml-variable:Double
m93309
10
infinite
0
TRANSFAC | G010329 |
--
TNF-alpha
--
MO000000289
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m230
10
infinite
0
InterPro | IPR003636 |
TRANSPATH | MO000000289 |
--
c-Jun:c-Fos(AP-1)
--
MO000055986
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m31310
10
infinite
0
TRANSPATH | MO000055986 |
--
aconitate hydratase
--
MO000088573
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m62266
10
infinite
0
TRANSPATH | MO000088573 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
KC
--
e11
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m11
0
infinite
0
--
IFNgamma R
--
e12
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m12
0
infinite
0
--
IFNgamma:R
--
e13
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m13
0
infinite
0
--
PMA
--
e14
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m14
0
infinite
0
--
ionophore
--
e15
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m15
0
infinite
0
--
TNF-alpha:receptor
--
e16
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m16
0
infinite
0
--
TNF-alpha receptor
--
e17
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
csml-variable:Double
m17
0
infinite
0
--
Phorbol ester TPA
--
e18
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m18
0
infinite
0
--
cAMP
--
e19
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
PGE2(exogenous)
--
e20
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
csml-variable:Double
m20
0
infinite
0
--
Theophylline
--
e21
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m21
0
infinite
0
--
AMP
--
e22
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m22
0
infinite
0
--
L.donovani
--
e23
cso30:c:Cell
cso30:i:CC_Extracellular
--
csml-variable:Double
m23
0
infinite
0
--
PGE2
--
e24
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m24
0
infinite
0
--
Il-1
--
e25
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m25
0
infinite
0
--
LPG
--
e26
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
csml-variable:Double
m26
0
infinite
0
--
TNFAR
--
e27
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m27
0
infinite
0
--
Dibutyryl cAMP
--
e28
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m28
0
infinite
0
--
NO
--
e29
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
csml-variable:Double
m29
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
L-arginine
--
e30
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
csml-variable:Double
m30
0
infinite
0
--
NO synthase
--
e31
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m31
0
infinite
0
--
nitrite
--
e32
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m32
0
infinite
0
--
L-citrulline
--
e33
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m33
0
infinite
0
--
nitrate
--
e34
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m34
0
infinite
0
--
Labile Iron atoms
--
e35
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m35
0
infinite
0
--
L-NMMA
--
e36
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
csml-variable:Double
m36
0
infinite
0
--
neutralizing anti TNF-alpha antibody
--
e37
cso30:c:Protein
cso30:i:CC_Extracellular
--
csml-variable:Double
m37
0
infinite
0
--
L.major
--
e38
cso30:c:Cell
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m38
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
LPS:TLR4
--
e5
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
JE
--
e6
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
p1
p1
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c2 : 1
stoichiometry:c3 : 1
m155666*m3961*0.1
nodelay
--
0
PMID: 1757110, 3760571, 3108379 The fact that differences in TNF-o~ release could be measured at the protein level within 4 h of addition of priming/activating signals stimulated us to begin looking at changes in expression of other early response genes at the mRNA level, especially those like c-fos, c-myc, JE and KC which are known to be induced by LPS
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c24 : 1
stoichiometry:c25 : 1
m16*0.1
nodelay
--
0
PMID: 1757110, 3497923, 2537468 Expression of both c-fos and c-jun is stimulated by TNF-alpha.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c26 : 1
stoichiometry:c27 : 1
m93221*0.1
nodelay
--
0
PMID: 1757110 In the case of c-fos, the protein product for the gene dimerises with c-jun to form the TRE binding protein complex AP-1, c-fos itself having both TRE and CRE in its promoter region.
p12
p12
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c30 : 1
stoichiometry:c31 : 1
stoichiometry:c32 : 1
m221*m46*0.1
nodelay
--
0
PMID: 1757110 In the case of c-fos, the protein product for the gene dimerises with c-jun to form the TRE binding protein complex AP-1, c-fos itself having both TRE and CRE in its promoter region.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c28 : 1
stoichiometry:c29 : 1
m93203*0.1
nodelay
--
0
PMID: 1757110 In the case of c-fos, the protein product for the gene dimerises with c-jun to form the TRE binding protein complex AP-1, c-fos itself having both TRE and CRE in its promoter region.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c33 : 1
stoichiometry:c34 : 1
m18*0.1
nodelay
--
0
PMID: 1757110 TNF-o~ stimulates prolonged expression at the mRNA level contrasting with transient induction observed with the phorbol ester TPA.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c35 : 1
stoichiometry:c37 : 1
stoichiometry:c73 : 1
stoichiometry:c92 : 1
stoichiometry:c95 : 1
stoichiometry:c41 : 1
m16*m30*m31*0.1
nodelay
--
0
PMID: 1757110, 2279740, 2175327 In the context of the L. major model, Liew and co-workers have shown that, in the presence of 10ng/ml LPS, recombinant TNF-et acts synergistically with interferon-3, to give maximal production of INO and antileishmanial activity. PMID: 1757110, 2999236 This was confirmed by Green and co-workers [47] who showed that neutralizing anti-TNF-a antibodies blocked production of INO and antileishmanial activity in interferon-3, primed peritoneal macrophages. PMID: 1757110, 1712077, 2432665, 3242600 In this system, L-arginine is oxidised by an inducible NADPHdependent enzyme (NO synthase) to yield L-citrulline, nitrite and nitrate, with highly reactive nitric oxide (NO) produced as an intermediate. The degree of kill correlated well with the levels of nitrites measured in the supernatants at 72 h, and inclusion of 200 #M L-NMMA, a competitive inhibitor of the L-arginine dependent pathway for the synthesis of INO, inhibited the killing
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c39 : 1
stoichiometry:c38 : 1
stoichiometry:c40 : 1
m19*0.1
nodelay
--
0
PMID: 1757110 This could involve differences in down regulation of LPS or TNF-a receptors, or a cAMPdependent down regulation of TNF-o~ production. In preliminary experiments (T. I.A. Roach and J.M. Blackwell, unpublished) we have established that either addition of exogenous prostaglandin E2, or inhibition of cAMP catabolism with theophylline, reduces TNF-ot release.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c36 : 1
stoichiometry:c42 : 1
stoichiometry:c74 : 1
stoichiometry:c93 : 1
stoichiometry:c96 : 1
stoichiometry:c43 : 1
m5*m30*m31*0.1
nodelay
--
0
PMID: 1757110, 2279740, 2175327 In the context of the L. major model, Liew and co-workers have shown that, in the presence of 10ng/ml LPS, recombinant TNF-et acts synergistically with interferon-3, to give maximal production of INO and antileishmanial activity. PMID: 1757110, 2999236 This was confirmed by Green and co-workers [47] who showed that neutralizing anti-TNF-a antibodies blocked production of INO and antileishmanial activity in interferon-3, primed peritoneal macrophages. PMID: 1757110, 1712077, 2432665, 3242600 In this system, L-arginine is oxidised by an inducible NADPHdependent enzyme (NO synthase) to yield L-citrulline, nitrite and nitrate, with highly reactive nitric oxide (NO) produced as an intermediate. The degree of kill correlated well with the levels of nitrites measured in the supernatants at 72 h, and inclusion of 200 #M L-NMMA, a competitive inhibitor of the L-arginine dependent pathway for the synthesis of INO, inhibited the killing
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c45 : 1
stoichiometry:c48 : 1
stoichiometry:c44 : 1
m25*0.1
nodelay
--
0
PMID: 1757110, 3917283, 2112157 Previous studies have shown, for example, that L. donovani is a potent stimulator of prostaglandin E2 synthesis in BALB/ c (Lsh s) macrophages, and that preinfection of macrophages selectively diminishes IL-1 (but not TNF-ot) production.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c46 : 1
stoichiometry:c47 : 1
m23*0.1
nodelay
--
0
PMID: 1757110, 3917283, 2112157 Previous studies have shown, for example, that L. donovani is a potent stimulator of prostaglandin E2 synthesis in BALB/ c (Lsh s) macrophages, and that preinfection of macrophages selectively diminishes IL-1 (but not TNF-ot) production.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c5 : 1
m5*0.1
nodelay
--
0
PMID: 1757110, 3760571, 3108379 The fact that differences in TNF-o~ release could be measured at the protein level within 4 h of addition of priming/activating signals stimulated us to begin looking at changes in expression of other early response genes at the mRNA level, especially those like c-fos, c-myc, JE and KC which are known to be induced by LPS
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c51 : 1
stoichiometry:c50 : 1
m26*0.1
nodelay
--
0
PMID: 1757110, 1707920 More recently, Descoteaux and co-workers have shown that parasite-derived lipophosphoglycan (LPG) stimulates rapid expression of both c-fos and TNF-a genes
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c49 : 1
stoichiometry:c52 : 1
m26*0.1
nodelay
--
0
PMID: 1757110, 1707920 More recently, Descoteaux and co-workers have shown that parasite-derived lipophosphoglycan (LPG) stimulates rapid expression of both c-fos and TNF-a genes
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c53 : 1
stoichiometry:c54 : 1
1.0*0.1
nodelay
--
0
PMID: 1757110 LPG induced a rapid down-modulation of TNF-a receptors but did not impair stimulation of expression of c-fos by the cAMP analogue, dibutyryl cAMP.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c55 : 1
stoichiometry:c56 : 1
m27*0.1
nodelay
--
0
PMID: 1757110 LPG induced a rapid down-modulation of TNF-a receptors but did not impair stimulation of expression of c-fos by the cAMP analogue, dibutyryl cAMP.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c57 : 1
stoichiometry:c58 : 1
m28*0.1
nodelay
--
0
PMID: 1757110 LPG induced a rapid down-modulation of TNF-a receptors but did not impair stimulation of expression of c-fos by the cAMP analogue, dibutyryl cAMP.
p26
p26
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c64 : 1
stoichiometry:c66 : 1
stoichiometry:c68 : 1
stoichiometry:c91 : 1
stoichiometry:c65 : 1
m93309*m5*0.1
nodelay
--
0
PMID: 1757110, 2999236 The LPS itself acts as a potent stimulator of TNF-ct release, which may then form an autocrine loop acting back on the macrophage. PMID: 1757110 This could involve differences in down regulation of LPS or TNF-a receptors, or a cAMPdependent down regulation of TNF-o~ production. In preliminary experiments (T. I.A. Roach and J.M. Blackwell, unpublished) we have established that either addition of exogenous prostaglandin E2, or inhibition of cAMP catabolism with theophylline, reduces TNF-ot release.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c61 : 1
stoichiometry:c62 : 1
stoichiometry:c63 : 1
m29*m62266*0.1
nodelay
--
0
PMID: 1757110, 3745439, 2451695, 2497225 NO mediates L-arginine dependent tumour cyo tostasis during co-culture with interferon-7 and LPS activated macrophages, possibly via nitrosylation reactions which remove labile iron atoms from Fe-S prosthetic groups of aconitase and complexes I and II of the mitochondrial electron transport system
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c75 : 1
stoichiometry:c77 : 1
stoichiometry:c78 : 1
stoichiometry:c79 : 1
stoichiometry:c94 : 1
stoichiometry:c76 : 1
m30*m31*m13*0.1
nodelay
--
0
PMID: 1757110, 2279740, 2175327 In the context of the L. major model, Liew and co-workers have shown that, in the presence of 10ng/ml LPS, recombinant TNF-et acts synergistically with interferon-3, to give maximal production of INO and antileishmanial activity. PMID: 1757110, 2999236 This was confirmed by Green and co-workers [47] who showed that neutralizing anti-TNF-a antibodies blocked production of INO and antileishmanial activity in interferon-3, primed peritoneal macrophages. PMID: 1757110, 1712077, 2432665, 3242600 In this system, L-arginine is oxidised by an inducible NADPHdependent enzyme (NO synthase) to yield L-citrulline, nitrite and nitrate, with highly reactive nitric oxide (NO) produced as an intermediate. The degree of kill correlated well with the levels of nitrites measured in the supernatants at 72 h, and inclusion of 200 #M L-NMMA, a competitive inhibitor of the L-arginine dependent pathway for the synthesis of INO, inhibited the killing
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c7 : 1
stoichiometry:c6 : 1
m5*0.1
nodelay
--
0
PMID: 1757110, 3760571, 3108379 The fact that differences in TNF-o~ release could be measured at the protein level within 4 h of addition of priming/activating signals stimulated us to begin looking at changes in expression of other early response genes at the mRNA level, especially those like c-fos, c-myc, JE and KC which are known to be induced by LPS
p30
p30
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c80 : 1
stoichiometry:c82 : 1
stoichiometry:c67 : 1
stoichiometry:c90 : 1
stoichiometry:c81 : 1
m93309*m38*0.1
nodelay
--
0
PMID:1757110 In this case, the parasite (L. major) itself acted as the stimulus for TNF-a release by the macrophage. PMID: 1757110 This could involve differences in down regulation of LPS or TNF-a receptors, or a cAMPdependent down regulation of TNF-o~ production. In preliminary experiments (T. I.A. Roach and J.M. Blackwell, unpublished) we have established that either addition of exogenous prostaglandin E2, or inhibition of cAMP catabolism with theophylline, reduces TNF-ot release.
p31
p31
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c83 : 1
stoichiometry:c85 : 1
stoichiometry:c69 : 1
stoichiometry:c71 : 1
stoichiometry:c84 : 1
m23*m93309*0.1
nodelay
--
0
PMID: 1757110 The magnitude of this response was enhanced in macrophages preinfected with L. donovani amastigotes, suggesting again that the parasite itself may act as a trigger for TNF-ct production/release. PMID: 1757110 This could involve differences in down regulation of LPS or TNF-a receptors, or a cAMPdependent down regulation of TNF-o~ production. In preliminary experiments (T. I.A. Roach and J.M. Blackwell, unpublished) we have established that either addition of exogenous prostaglandin E2, or inhibition of cAMP catabolism with theophylline, reduces TNF-ot release.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c86 : 1
stoichiometry:c87 : 1
stoichiometry:c88 : 1
stoichiometry:c89 : 1
m29*0.1
nodelay
--
0
PMID: 1757110, 1712077, 2432665, 3242600 In this system, L-arginine is oxidised by an inducible NADPHdependent enzyme (NO synthase) to yield L-citrulline, nitrite and nitrate, with highly reactive nitric oxide (NO) produced as an intermediate.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c8 : 1
stoichiometry:c9 : 1
m5*0.1
nodelay
--
0
PMID: 1757110, 3760571, 3108379 The fact that differences in TNF-o~ release could be measured at the protein level within 4 h of addition of priming/activating signals stimulated us to begin looking at changes in expression of other early response genes at the mRNA level, especially those like c-fos, c-myc, JE and KC which are known to be induced by LPS
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c10 : 1
stoichiometry:c15 : 1
stoichiometry:c11 : 1
m5*m13*0.1
nodelay
--
0
PMID: 1757110, 3760571, 3108379 The fact that differences in TNF-o~ release could be measured at the protein level within 4 h of addition of priming/activating signals stimulated us to begin looking at changes in expression of other early response genes at the mRNA level, especially those like c-fos, c-myc, JE and KC which are known to be induced by LPS PMID: 1757110 Priming with 33 units/ml interferon-3, along with l0 ng/ml LPS induced much higher levels of KC
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c12 : 1
stoichiometry:c13 : 1
stoichiometry:c14 : 1
m1639*m12*0.1
nodelay
--
0
PMID: 1757110 Priming with 33 units/ml interferon-3, along with l0 ng/ml LPS induced much higher levels of KC
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c16 : 1
stoichiometry:c17 : 1
stoichiometry:c18 : 1
m14*m15*0.1
nodelay
--
0
PMID: 1757110 For c-fos, differences in expression are observed within 20min following stimulation with PMA plus ionophore. In this case, however, resistant macrophages down-regulate expression from a higher baseline level while susceptible macrophages show enhanced expression over the 20-min time course.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c19 : 1
stoichiometry:c20 : 1
stoichiometry:c21 : 1
m230*m17*0.1
nodelay
--
0
PMID: 1757110, 3497923, 2537468 Expression of both c-fos and c-jun is stimulated by TNF-alpha.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c22 : 1
stoichiometry:c23 : 1
m16*0.1
nodelay
--
0
PMID: 1757110, 3497923, 2537468 Expression of both c-fos and c-jun is stimulated by TNF-alpha.
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--